Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$302M |
| 2 |
Advanced Micro Devices
AMD
|
+$270M |
| 3 |
Cardinal Health
CAH
|
+$257M |
| 4 |
Adobe
ADBE
|
+$221M |
| 5 |
Visa
V
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$257M |
| 2 |
Bank of America
BAC
|
+$245M |
| 3 |
Stanley Black & Decker
SWK
|
+$240M |
| 4 |
Coca-Cola
KO
|
+$232M |
| 5 |
Cisco
CSCO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.38% |
| 2 | Healthcare | 15.51% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Northrop Grumman
NOC
$77B
| $6.26M | 0.01% |
13,647
-3,053
| -18% | -$1.4M |
|
852
L3Harris
LHX
$55.9B
| $6.2M | 0.01% |
27,939
-4,954
| -15% | -$1.2M |
|
853
Berkshire Hathaway Class A
BRK.A
$1.07T
| $6.19M | 0.01% |
15
| – | – |
|
854
Adecoagro
AGRO
$1.53B
| $6.17M | 0.01% |
729,671
-58,210
| -7% | -$627K |
|
855
Neurocrine Biosciences
NBIX
$17.7B
| $6.15M | ﹤0.01% |
65,270
-581
| -0.9% | -$53.6K |
|
856
SI-BONE Inc
SIBN
$737M
| $6.12M | ﹤0.01% |
501,189
+50,845
| +11% | +$847K |
|
857
Cedar Fair
FUN
$1.78B
| $6.09M | ﹤0.01% |
151,670
+96,287
| +174% | +$4.67M |
|
|
FAX
858
abrdn Asia-Pacific Income Fund
FAX
$590M
| $6.08M | ﹤0.01% |
371,256
+362,787
| +4,284% | +$6.76M |
|
859
Amplify Cybersecurity ETF
HACK
$2.63B
| $6.07M | ﹤0.01% |
133,022
-14,700
| -10% | -$738K |
|
860
HEICO Corp Class A
HEI.A
$35.4B
| $6.05M | ﹤0.01% |
56,714
-6,644
| -10% | -$765K |
|
861
Entegris
ENTG
$19.7B
| $6.04M | ﹤0.01% |
63,944
+6,703
| +12% | +$726K |
|
862
Roku
ROKU
$21.1B
| $6.03M | ﹤0.01% |
73,243
+2,158
| +3% | +$209K |
|
|
XIFR
863
XPLR Infrastructure LP
XIFR
$1.18B
| $6.03M | ﹤0.01% |
81,750
-136,850
| -63% | -$9.82M |
|
864
Liberty Global Class A
LBTYA
$3.31B
| $5.91M | ﹤0.01% |
288,291
-116,830
| -29% | -$2.74M |
|
865
Spotify
SPOT
$99.2B
| $5.87M | ﹤0.01% |
60,907
-70,058
| -53% | -$7.9M |
|
866
Invesco DB Agriculture Fund
DBA
$1.26B
| $5.81M | ﹤0.01% |
297,800
| – | – |
|
867
WisdomTree India Earnings Fund ETF
EPI
$2.02B
| $5.81M | ﹤0.01% |
195,100
-31,900
| -14% | -$1.09M |
|
868
EastGroup Properties
EGP
$11.5B
| $5.78M | ﹤0.01% |
38,058
-11,624
| -23% | -$2.04M |
|
869
VanEck Gold Miners ETF
GDX
$23B
| $5.75M | ﹤0.01% |
223,838
+105,900
| +90% | +$3.57M |
|
870
Vale
VALE
$62.9B
| $5.66M | ﹤0.01% |
453,400
-25,751
| -5% | -$440K |
|
871
Fortis
FTS
$30B
| $5.64M | ﹤0.01% |
119,812
+5,117
| +4% | +$251K |
|
872
Invesco Senior Loan ETF
BKLN
$7.1B
| $5.64M | ﹤0.01% |
275,000
| – | – |
|
873
Brixmor Property Group
BRX
$9.95B
| $5.6M | ﹤0.01% |
281,874
-27,779
| -9% | -$657K |
|
|
OLPX
874
DELISTED
Olaplex Holdings
OLPX
| $5.58M | ﹤0.01% |
+377,648
| New | +$5.58M |
|
875
iShares Core MSCI Pacific ETF
IPAC
$2.6B
| $5.55M | ﹤0.01% |
108,718
+451
| +0.4% | +$25.3K |
|
Similar funds
Amundi's Q2 2022 Portfolio in Review
As of Q2 2022, Amundi held 1,750 positions worth $125B, down 16% from $148B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Amundi's Q2 2022 filing shows 104 new, 631 increased, 657 reduced and 91 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M. The largest sale was Procter & Gamble, an estimated $257M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Amundi's largest Q2 2022 buy was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M.
- Amundi added most to Freeport-McMoran in Q2 2022, an estimated $302M increase.
- Amundi's biggest Q2 2022 reduction was Procter & Gamble, cutting an estimated $257M.
- Amundi fully exited Cerner Corp in Q2 2022, selling an estimated $152M.
- Amundi's ten largest holdings make up 18% of its $125B portfolio in Q2 2022.
- Amundi opened 104 new positions and closed 91 in Q2 2022.
- Amundi's portfolio value fell 16% quarter-over-quarter to $125B.
Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.